The relationship between skin manifestations and CD4 counts among HIV positive patients

Pakistan Journal of Medical Sciences

Volumn 24, Issue 1, 2008, Pages 114-117

  Rad, Farrokh ^a   Ghaderi, Ebrahim ^b   Moradi, Ghobad ^b   Mafakheri, Latifeh ^b  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Kurdistan Province's Health Centre   (Iran)

Author keywords

CD4; HIV; Skin disease

Indexed keywords

ADULT; ARTICLE; BACTERIAL SKIN DISEASE; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; DERMATOLOGY; DESCRIPTIVE RESEARCH; FEMALE; FOLLICULITIS; GINGIVITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; MEDICAL SPECIALIST; MYCOSIS; PAKISTAN; PALLOR; PHOTOSENSITIVITY; PREVALENCE; PRURITUS; SEBORRHEIC DERMATITIS; SKIN EXAMINATION; SKIN MANIFESTATION; STUDENT T TEST; TINEA VERSICOLOR; VIRAL SKIN DISEASE;

EID: 40549103794     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. UNAIDS Report of the global HIV/AIDS Epidemic. Joint United Nations Programme on HIV/AIDS, Geneva 2003.
2. Mbuagbaw J, Eyong I, Alemnji G, Mpoudi N, Same-Ekobo A. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol 2006;45:280-4.
3. Bravo IM, Correnti M, Escalona L, Perrone M, Brito A, Tovar V, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal 2006;11:E1-5.
4. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with Human Immu-nodeficiency Virus infection in 1000 South Indian patients. Ann Acad Med Singapore 2004;33(4 Suppl):37-42.
5. Reichart PA, Khongkhunthian P, Bendick C. Oral Manifestations in HIV infected individuals from Thailand and Cambodia. Med Microbiol Immunol 2003;192(3):157-60.
6. Moniaci D, Greco D, Flecchia G, Raitieri R, Sinicco A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990;19(10):477-81.
7. Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: A note on 120 cases. Int J Dermatol 2004;43(4):265-8.
8. Kumarasamy N, Solomon S, Madhivanan P, Ravikumar B, Thyagarajan SP, Yesudian P. Dermatologic manifestations among human immunodeficiency virus patients in south India. Int J Dermatol 2000;39(3):192-5.
9. Coopman SA, Johnson RA, Platt R, Stern R. Cutaneous disease and drug reactions in HIV Infection. N Engl J Med 1993;328(23):1670-4.
10. Bakari M, Pallangyo K, Kitinya J, Mbena E, Urassa W. The importance of clinical features in differentiating HIV-related from non HIV-related Kaposi's sarcoma: Experience from Dar es salaam, Tanzania. Trop Doct 1996;26(3):104-7.
11. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization, Geneva; 2007:14.
12. Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, et al. Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study. Ann Intern Med 1999;130(7):570-7.
13. Yazdanpanah Y, Chêne G, Losina E, Goldie SJ, Merchadou LD, Alfandari S, et al. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol 2001; 30(4):864-71.
14. Margiotta V, Campisi G, Mancuso S, Accurso V, Abbadessa V. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. J Oral Pathol Med 1999;28(4):173-7.
15. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F, Colmenero MA. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol 1998;139(1):33-9.
16. Muhammad B, Eligius L, Mugusi F, Aris E, Chale S, Magao P, et al. The prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in Dar es Salaam. Trop Doct 2003;33(1):44-8.
17. Samet JH, Muz P, Cabral P, Jhamb K, Suwanchinda A, Freedberg KA. Dermatologic manifestations in HIV-infected patients: a primary care perspective. Mayo Clin Proc 1999 Jul;74(7):658-60.
18. Hira SK, Wadhawan D, Kamanga J, Kavindele D, Macuacua R, Patil PS, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol 1988 Sep;19(3):451-7.
19. Spira R, Mignard M, Doutre MS, Morlat P, Dabis F. Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. Arch Dermatol 1998 Oct;134(10):1290-2.
20. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: A review. J Infect Dis 1992 Feb;165(2):352-63.
21. Pitche P, Tchangaï-Walla K, Napo-Koura G, Mijiyawa M, Agbere A, Tatagan A. Prevalence of Skin Manifestations in AIDS Patients in the Lome-Tkom University Hospital (Togo). Sante 1995;5(6):349-52.
22. Eichmann A. Skin manifestations in patients with HIV infection. Z Hautkr 1990;65(7):640-4.
23. Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore 1995;24(4):528-33.
24. Michelim L, Atti JL, Panarotto D, Lovatto L, Boniatti MM. Dermatological disease among HIV-infected patients with CD4-lymphocyte count. Rev Saude Publica 2004;38(6):758-63.
25. Reynaud-Mendel B, Janier M, Gerbaka J, Hakim C, Rabian C, Chastang C, et al. Dermatologic findings in HIV-1-infected patients: A prospective study with emphasis on CD4+ cell count. Dermatology 1996;192(4):325-8.